Preserving adult height potential in girls with idiopathic true precocious puberty (Q47442837)

16 January 2018

title

Preserving adult height potential in girls with idiopathic true precocious puberty (English)

1 reference

16 January 2018

author name string

Kreiter M

1

1 reference

16 January 2018

Burstein S

2

1 reference

16 January 2018

Rosenfield RL

3

1 reference

16 January 2018

Moll GW Jr

4

1 reference

16 January 2018

Cara JF

5

1 reference

16 January 2018

Yousefzadeh DK

6

1 reference

16 January 2018

Cuttler L

7

1 reference

16 January 2018

Levitsky LL

8

1 reference

16 January 2018

language of work or name

English

0 references

publication date

1 September 1990

1 reference

16 January 2018

The Journal of Pediatrics

published in

1 reference

16 January 2018

volume

117

1 reference

16 January 2018

issue

3

1 reference

16 January 2018

page(s)

364-370

1 reference

16 January 2018

Precocious puberty. A report of 96 cases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Precocious puberty: a follow up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Cyproterone acetate in treatment of precocious puberty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

The effects of cyproterone acetate on statural growth in children with precocious puberty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Intranasal nafarelin: an LH-RH analogue treatment of gonadotropin-dependent precocious puberty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Intranasal and subcutaneous treatment of central precocious puberty in both sexes with a long-acting analog of luteinizing hormone-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

The treatment of central precocious puberty using an intranasal LHRH analogue (buserelin).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Effects of leuprolide in the treatment of central precocious puberty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

7 January 2021

Skeletal age prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Bayley-Pinneau, Roche-Wainer-Thissen, and Tanner height predictions in normal children and in patients with various pathologic conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Standards for children's height at ages 2-9 years allowing for heights of parents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Pelvic ultrasonography in girls with precocious puberty, congenital adrenal hyperplasia, obesity, or hirsutism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Pitfalls in the somatomedin-C radioimmunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Immunoreactivity and receptor binding of mixed recombinants of human growth hormone and chorionic somatomammotropin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (nafarelin).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Somatomedin-C in accelerated growth of children with precocious puberty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Effect of low doses of estradiol on 6-month growth rates and predicted height in patients with Turner syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Growth in Turner's syndrome: long term treatment with low dose ethinyl estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

Precocious puberty in girls: early diagnosis of a slowly progressing variant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981074-1

10.1016/S0022-3476(05)81074-1

7 January 2021

Identifiers

DOI

1 reference

16 January 2018

PubMed ID

2144020

1 reference

16 January 2018